August 11, 2005

FOR RELEASE:  Immediately

CTS Chosen by Cameron Health, Inc. to Produce Internal Heart Defibrillator

Elkhart, IN… CTS Corporation (NYSE:CTS), a leading provider of electronics manufacturing services, announced today that it has entered into an agreement with Cameron Health, Inc. of San Clemente, California, to produce its next generation of implantable cardioverting defibrillators utilizing state-of-the-art technologies.  This internal heart defibrillator provides improved patient treatment by automatically engaging when there is an interruption in the heart’s arrhythmia.

CTS Electronics Manufacturing Solutions has collaborated with Cameron Health on the new program from the earlier design phases through the new product introduction.

Dave Hackbarth, Cameron Health vice president of operations commented, “Working with CTS Electronics Manufacturing Solutions has been a key factor in our bringing our new program to market in half the time it typically takes to launch such a sophisticated product.  Teams from both companies worked side-by-side on some aspects of the design and prototyping, and we were able to avoid many of the unforeseeable problems that can crop up in developing and introducing a medical device of this significance.”

“We are pleased to play an even greater role in such a strategically important new product line for Cameron Health,” said Don Schroeder, CTS Electronics Manufacturing Solutions president. “By collaborating throughout the design and new product introduction phases, we have been able to achieve the aggressive time-to-market target of this product.  The decision to use CTS Electronics Manufacturing Solutions to manufacture it demonstrates our ability to add value throughout the product life cycle, starting with the earliest phase of product design,” stated Schroeder.

CTS Electronics Manufacturing Solutions anticipates that the initial manufacturing phase will commence in the first half of calendar 2006.

About CTS Electronics Manufacturing Solutions

CTS’ EMS business offers core expertise in supporting the needs of medical customers. Key capabilities include design services, high-reliability surface mount assembly for high complexity electronics, fully integrated boxbuild systems, global support for clinical trials and cleanroom manufacturing. Manufacturing operations are located in North America, Europe and Asia.

For more information on CTS’ medical and related products, please contact Bob Miller at (805) 532-2800 (North America) and Sarah Hughes at 011-44-1698-505003 (Europe).

#  #  #  #

About CTS

CTS is a leading designer and manufacturer of electronic components and sensors and a provider of electronics manufacturing services (EMS) to OEMs in the automotive, computer, communications, medical and industrial markets.  CTS manufactures products in North America, Europe and Asia. CTS' stock is traded on the NYSE under the ticker symbol "CTS." 

Safe Harbor Statement

This press release contains certain statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include, but are not limited to, statements regarding the business and strategic benefits of the SMTEK acquisition, any financial or other guidance, and all statements that are not based on historical fact, but rather reflect our current expectations concerning future results and events.  We make certain assumptions when making forward-looking statements, any of which could prove inaccurate, including, but not limited to, statements about our future operating results and business plans.  The ultimate correctness of these forward-looking statements is dependent upon a number of known and unknown risks and events, and is subject to various uncertainties and other factors that may cause our actual results, performance, or achievements to be different from any future results, performance, or achievements expressed or implied by these statements.

For more detailed information on the risks and uncertainties associated with CTS' business activities, see our reports filed with the SEC.  CTS undertakes no obligation to publicly update its forward-looking statements, whether as a result of market or industry changes, new information or future events.